# OnCo record algenpantucel-l (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/algenpantucel-l/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "algenpantucel-l" ;
  schema:name "Algenpantucel-L"@en ;
  schema:alternateName "HyperAcute Pancreas"@en ;
  schema:description "Algenpantucel-L was a whole-cell pancreatic cancer vaccine given after surgery; the phase 3 IMPRESS trial showed no survival benefit."@en ;
  schema:url <https://onco.cc/drugs/algenpantucel-l/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01072981> ;
  onco:status "negative" ;
  onco:modality "Allogeneic whole-cell vaccine expressing alpha-gal" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:companies <https://onco.cc/companies/newlink-genetics/> ;
  onco:terms <https://onco.cc/terms/vaccines-and-oncolytic-viruses/> ;
  onco:trials <https://onco.cc/trials/impress-trial/> .